Cargando…
Safety, Tolerability, and Physiological Effects of AXA1665, a Novel Composition of Amino Acids, in Subjects With Child–Pugh A and B Cirrhosis
INTRODUCTION: AXA1665 is a novel investigational amino acid (AA) composition specifically designed to impact AA imbalance, ammoniagenesis, and dysregulated anabolic activity associated with cirrhosis. METHODS: This 2-part study examined AXA1665 effects on safety, tolerability, and hepatic/muscle phy...
Autores principales: | Chakravarthy, Manu V., Neutel, Joel, Confer, Scharmen, Zhao, Peng, Tatsuta, Noriaki, Rebello, Sam, Comb, William C., Hamill, Michael, Tramontin, Tony, Carroll, Sean, Afeyan, Raffi, Sanyal, Arun J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7423914/ https://www.ncbi.nlm.nih.gov/pubmed/32955200 http://dx.doi.org/10.14309/ctg.0000000000000222 |
Ejemplares similares
-
Endogenous Metabolic Modulators: Emerging Therapeutic Potential of Amino Acids
por: Hamill, Michael J., et al.
Publicado: (2020) -
A Novel Amino Acid Composition Ameliorates Short-Term Muscle Disuse Atrophy in Healthy Young Men
por: Holloway, Tanya M., et al.
Publicado: (2019) -
A novel, multitargeted endogenous metabolic modulator composition impacts metabolism, inflammation, and fibrosis in nonalcoholic steatohepatitis-relevant primary human cell models
por: Daou, Nadine, et al.
Publicado: (2021) -
Safety, Tolerability, and Biologic Activity of AXA1125 and AXA1957 in Subjects With Nonalcoholic Fatty Liver Disease
por: Harrison, Stephen A., et al.
Publicado: (2021) -
AXA Winterthur
por: Staff Association
Publicado: (2020)